|
|
Line 674: |
Line 674: |
| |} | | |} |
| |} | | |} |
|
| |
| ==Classification==
| |
| Acute liver failure may be classified on the basis of the duration of the [[symptoms]] between the onset of [[jaundice]] to the onset of [[encephalopathy]]. The different classification systems based on the number of weeks from the appearance of jaundice to the encephalopathy are:
| |
|
| |
| {| class="wikitable"
| |
| ! Classification system!! Duration
| |
| |-
| |
| | O’Grady System||
| |
| * Hyperacute (0 - 1 week)
| |
| * Acute ( From 2nd week - 4 weeks)
| |
| * Subacute ( From 4th week - 12 weeks)
| |
| |-
| |
| | Bernuau System||
| |
| * Fulminant ( 0 - 2 weeks)
| |
| * Subfulminant ( 2 weeks - 12 weeks)
| |
| |-
| |
| |Japanese System ||
| |
| * Fulminant (0 - 8 weeks)
| |
| ** Acute ( 0 - 1.5 weeks)
| |
| ** Subacute ( 1.5 weeks - 8 weeks)
| |
|
| |
| * Late-Onset ( 8 weeks - 12 weeks)
| |
| |}
| |
|
| |
| The 1993 classification defines three subcategories based on the severity and duration of the acute liver failure. <ref>O'Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. ''[[The Lancet|Lancet]] 1993;342:273-5. PMID 8101303.''</ref> The importance of this method of classification is that the pace of the disease evolution strongly influences prognosis. The underlying [[etiology]] causing the development of acute liver failure is the other significant determinant in regards to prognosis.<ref name="ogredy1">{{cite journal |author=O'Grady JG |title=Acute liver failure |journal=Postgraduate medical journal |volume=81 |issue=953 |pages=148-54 |year=2005 |pmid=15749789 |doi=10.1136/pgmj.2004.026005}}</ref> This classification system is based upon the duration between onset of [[jaundice]] to onset of [[encephalopathy]].
| |
|
| |
| {| class="wikitable"
| |
| ! Classification!! Time
| |
| |-
| |
| | Hyperacute|| 1 week
| |
| |-
| |
| | Acute|| 1 week - 1 month
| |
| |-
| |
| |Subacute || 1 week - 3 months
| |
| |}
| |
|
| |
| Acute liver failure can also be classified into fulminant or subfulminant. Both of these forms have a poor prognosis. It is based upon the duration between onset of hepatic illness, to the development of encephalopathy.<ref name="pmid9027947">{{cite journal |author=Williams R |title=Classification, etiology, and considerations of outcome in acute liver failure |journal=[[Seminars in Liver Disease]] |volume=16 |issue=4 |pages=343–8 |year=1996 |month=November |pmid=9027947 |doi=10.1055/s-2007-1007247 |url=http://www.thieme-connect.com/DOI/DOI?10.1055/s-2007-1007247 |accessdate=2012-10-26}}</ref>
| |
| {| class="wikitable"
| |
| ! Classification !! Time
| |
| |-
| |
| |Fulminant || within 2 months
| |
| |-
| |
| |Subfulminant || within 2 months to 6 months
| |
| |}
| |
|
| |
| ===O’Grady System===
| |
| The classification of encephalopathy according to the O’Grady system is as follows.<ref name="O'Grady-1993">{{Cite journal | last1 = O'Grady | first1 = JG. | last2 = Schalm | first2 = SW. | last3 = Williams | first3 = R. | title = Acute liver failure: redefining the syndromes. | journal = Lancet | volume = 342 | issue = 8866 | pages = 273-5 | month = Jul | year = 1993 | doi = | PMID = 8101303 }}</ref>
| |
|
| |
| ====Hyperacute====
| |
| Hyperacute encephalopathy is an encephalopathy that occurs within 7 days of onset of jaundice.
| |
|
| |
| ====Acute====
| |
| Acute encephalopathy is an encephalopathy that occurs within an interval of 8 to 28 days from onset of jaundice.
| |
|
| |
| ====Subacute====
| |
| Subacute encephalopathy is an encephalopathy that occurs within 5 to 12 weeks of onset of jaundice.
| |
|
| |
| ===Bernuau System===
| |
| The classification of encephalopathy according to the Bernuau system is as follows.<ref name="Bernuau-1986">{{Cite journal | last1 = Bernuau | first1 = J. | last2 = Rueff | first2 = B. | last3 = Benhamou | first3 = JP. | title = Fulminant and subfulminant liver failure: definitions and causes. | journal = Semin Liver Dis | volume = 6 | issue = 2 | pages = 97-106 | month = May | year = 1986 | doi = 10.1055/s-2008-1040593 | PMID = 3529410 }}</ref>
| |
|
| |
| ====Fulminant====
| |
| Fulminant encephalopathy is an encephalopathy that occurs within 2 weeks of onset of jaundice.
| |
|
| |
| ====Subfulminant====
| |
| Subfulminant encephalopathy is an encephalopathy that occurs within an interval of 2 to 12 weeks from onset of jaundice.
| |
|
| |
| ====Japanese System====
| |
| The classification of encephalopathy according to the Bernuau system is as follows.<ref name="Mochida-2008">{{Cite journal | last1 = Mochida | first1 = S. | last2 = Nakayama | first2 = N. | last3 = Matsui | first3 = A. | last4 = Nagoshi | first4 = S. | last5 = Fujiwara | first5 = K. | title = Re-evaluation of the Guideline published by the Acute Liver Failure Study Group of Japan in 1996 to determine the indications of liver transplantation in patients with fulminant hepatitis. | journal = Hepatol Res | volume = 38 | issue = 10 | pages = 970-9 | month = Oct | year = 2008 | doi = 10.1111/j.1872-034X.2008.00368.x | PMID = 18462374 }}</ref>
| |
|
| |
| ====Fulminant====
| |
| Fulminant encephalopathy is an encephalopathy that occurs within 8 weeks of onset of jaundice.
| |
|
| |
| ====Late-Onset====
| |
| Late onset encephalopathy is an encephalopathy that occurs within an interval of 8 to 24 weeks from onset of jaundice.
| |
|
| |
| ====Acute====
| |
| Acute encephalopathy is an encephalopathy that occurs within 10 days of onset of jaundice
| |
|
| |
| ====Subacute====
| |
| Subacute encephalopathy is an encephalopathy that occurs within an interval of 11 to 56 days from onset of jaundice
| |
| <references />
| |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Differential diagnosis
Abbreviations:
COPD= Chronic obstructive pulmonary disease,
Causes of cyanosis
|
Disease
|
Cyanosis
|
Clinical manifestations/association
|
Diagnosis
|
Additional
findings
|
Symptoms
|
Signs
|
Peripheral
|
Central
|
Dyspnea
|
Fever
|
Chest pain
|
Clubbing
|
Peripheral edema
|
Auscultation
|
Lab Findings
|
Imaging
|
Gold standard
|
Respiratory
|
Airway
disorder
|
Croup
|
✔
|
|
|
|
|
|
+
|
+
|
|
|
|
|
Epiglottitis
|
✔
|
|
|
+
|
−
|
−
|
−
|
−
|
|
|
|
|
Foreign body aspiration
|
|
|
|
+
|
+
|
−
|
−
|
−
|
|
|
|
|
Airway trauma
|
|
|
|
+
|
+
|
±
|
−
|
−
|
|
|
|
|
Disease
|
Peripheral
|
Central
|
Dyspnea
|
Fever
|
Chest pain
|
Clubbing
|
Peripheral edema
|
Auscultation
|
Lab Findings
|
Imaging
|
Gold standard
|
Additional findings
|
Parenchymal
disorder
|
Pulmonary embolism
|
|
|
|
−
|
|
−
|
−
|
−
|
|
|
|
- Dyspnea
- Tachycardia
- Pleuretic chest pain
|
Pneumonia
|
|
|
|
−
|
−
|
−
|
−
|
−
|
- ABGs
- Leukocytosis
- Pancytopenia
|
- CXR
- CT chest
- Bronchoscopy
|
|
- Shortness of breath
- Cough
|
Asthma
(Late)
|
|
|
|
+
|
−
|
−
|
−
|
−
|
|
|
|
|
Cystic fibrosis
|
|
|
|
±
|
±
|
−
|
−
|
−
|
|
|
|
|
COPD
(Emphysema)
|
|
|
|
±
|
+
|
|
|
|
|
|
|
|
Empyema
|
|
|
|
±
|
+
|
−
|
−
|
−
|
|
Chest X-ray
|
|
Physical examination
|
Disease
|
Peripheral
|
Central
|
Dyspnea
|
Fever
|
Chest pain
|
Clubbing
|
Peripheral edema
|
Auscultation
|
Lab Findings
|
Imaging
|
Gold standard
|
Additional findings
|
Chest
wall
disorders
|
Flail chest
|
|
|
|
−
|
±
|
−
|
−
|
−
|
|
|
|
|
Pneumothorax
|
|
|
|
−
|
±
|
−
|
−
|
−
|
|
|
|
|
Hemothorax
|
|
|
|
−
|
+
|
±
|
−
|
−
|
|
|
|
|
Cardiovascular
|
Congenital
heart diseases
|
Disease
|
Peripheral
|
Central
|
Dyspnea
|
Fever
|
Chest pain
|
Clubbing
|
Peripheral edema
|
Auscultation
|
Lab Findings
|
Imaging
|
Gold standard
|
Additional findings
|
Atrioventricular canal defect
|
|
✔
|
|
+
|
|
|
|
+
|
|
|
|
|
Ebstein anomaly
|
|
✔
|
|
|
|
|
|
|
|
|
|
|
Hypoplastic left heart syndrome
|
|
✔
|
|
|
|
|
|
|
|
|
|
|
Pulmonary atresia
|
|
✔
|
|
|
|
|
|
|
|
|
|
|
Tetralogy of Fallot
|
|
✔
|
|
|
|
|
|
|
|
|
|
|
Pulmonic stenosis
|
|
✔
|
|
|
|
|
|
|
|
|
|
|
Total anomalous pulmonary venous drainage
|
|
✔
|
|
|
|
|
|
|
|
|
|
|
Transposition of the great vessels
|
|
✔
|
|
|
|
|
|
|
|
|
|
|
Truncus arteriosus
|
|
✔
|
|
|
|
|
|
|
|
|
|
|
|
Disease
|
Peripheral
|
Central
|
Dyspnea
|
Fever
|
Chest pain
|
Clubbing
|
Peripheral edema
|
Auscultation
|
Lab Findings
|
Imaging
|
Gold standard
|
Additional findings
|
Heart failure
|
|
|
|
+
|
−
|
+
|
±
|
+
|
|
|
|
|
Valvular heart disease
|
|
|
|
+
|
−
|
−
|
−
|
−
|
|
|
|
|
Myocardial infarction
|
|
|
|
−
|
−
|
−
|
−
|
−
|
|
|
|
|
Hematologic
|
Methemoglobinemia
|
|
✔
|
|
|
|
|
|
|
|
|
|
|
Polycythemia
|
|
✔
|
|
|
|
|
|
|
|
|
|
|
Central Nervous system
|
|
Peripheral
|
Central
|
Dyspnea
|
Fever
|
Chest pain
|
Clubbing
|
Peripheral edema
|
Auscultation
|
Lab Findings
|
Imaging
|
Gold standard
|
Additional findings
|
Coma
|
✔
|
|
|
|
|
|
|
|
|
|
|
|
Seizures
|
✔
|
|
|
|
|
|
|
|
|
|
|
|
Head trauma
|
✔
|
|
|
|
|
|
|
|
|
|
|
|
Breath holding spells
|
✔
|
|
|
|
|
|
|
|
|
|
|
|
Miscellaneous
|
Shock
|
✔
|
|
|
|
|
|
|
|
|
|
|
|
Smoke inhalation
|
|
|
|
+
|
+
|
|
|
+
|
|
|
|
|
Toxic gases
|
|
|
|
+
|
+
|
+
|
+
|
±
|
|
|
|
|
Cold exposure
|
✔
|
−
|
|
−
|
−
|
−
|
−
|
−
|
- Fingerstick glucose (Hyperglycemia)
- Electrocardiogram (ECG) may show J wave, sinus bradycardia and prolongation of all ECG intervals.
- Serum electrolytes (including potassium and calcium)
- Serum hemoglobin, white blood cell, and platelet counts ( Raised HCT due to volume contraction)
- Coagulation profile (clotting factors impairment)
- Serum lactate ( lactic acidosis)
- Creatine kinase (Rhabdomylosis)
|
|
|
* Mild hypothermia: core temperature 32 to 35°C ; patient presents with confusion, tachycardia, and increased shivering.
- Moderate hypothermia: 28 to 32°C patient presents with lethargy, bradycardia and arrhythmia and decreased shivering.
- Severe hypothermia: below 28°C patient presents with coma, hypotension, arrhythmia, pulmonary edema, and rigidity.
|
Drugs†
|
|
|
|
−
|
−
|
−
|
−
|
−
|
|
|
|
|
|